COLLECTION AND ANALYSIS OF DRUG SAFETY DATA IN PREGNANCY
Main Article Content
Keywords
DRUG SAFETY, PREGNANCY
Abstract
Much of what I will touch on will be taken from the perspective of Motherisk, where we as service providers speak to patients and practitioners on a day to day basis.
References
1. Moretti M, Koren G. Motherisk: The Toronto Model for Counseling in Reproductive Toxicology. 2004: 767-789.
2. Bonati M, Bortolus R, Marchetti F, Romero M, Tognoni G. Drug use in pregnancy: an overview of epidemiological (drug utilization) studies. Eur J Clin Pharmacol 1990;38:325-328.
3. Reiff-Eldridge R, Heffner CR, Ephross SA, Tennis PS, White AD, Andrews EB. Monitoring pregnancy outcomes after prenatal drug exposure
through prospective pregnancy registries: a pharmaceutical company commitment. Am J Obstet Gynecol 2000;182:159-163.
4. US Food and Drug Administration. Guidance for industry establishing pregnancy exposure registries. Rockville (MD): US Department of
Health and Human Services; 2002.
5. Rosa F. Databases in the assessment of the effects of drugs during pregnancy. J Allergy Clin Immunol 1999;103:S360-S361.
6. Axelsson O. The Swedish medical birth register. Acta Obstet Gynecol Scand 2003;82:491-492.
7. Moretti ME, Caprara D, Coutinho CJ et al. Fetal safety of loratadine use in the first trimester of pregnancy: a multicenter study. J Allergy Clin
Immunol 2003;111:479-483.
2. Bonati M, Bortolus R, Marchetti F, Romero M, Tognoni G. Drug use in pregnancy: an overview of epidemiological (drug utilization) studies. Eur J Clin Pharmacol 1990;38:325-328.
3. Reiff-Eldridge R, Heffner CR, Ephross SA, Tennis PS, White AD, Andrews EB. Monitoring pregnancy outcomes after prenatal drug exposure
through prospective pregnancy registries: a pharmaceutical company commitment. Am J Obstet Gynecol 2000;182:159-163.
4. US Food and Drug Administration. Guidance for industry establishing pregnancy exposure registries. Rockville (MD): US Department of
Health and Human Services; 2002.
5. Rosa F. Databases in the assessment of the effects of drugs during pregnancy. J Allergy Clin Immunol 1999;103:S360-S361.
6. Axelsson O. The Swedish medical birth register. Acta Obstet Gynecol Scand 2003;82:491-492.
7. Moretti ME, Caprara D, Coutinho CJ et al. Fetal safety of loratadine use in the first trimester of pregnancy: a multicenter study. J Allergy Clin
Immunol 2003;111:479-483.
Article Sidebar
Published
Dec 8, 2018
Article Details
How to Cite
Moretti, M. (2018). COLLECTION AND ANALYSIS OF DRUG SAFETY DATA IN PREGNANCY. Journal of Population Therapeutics and Clinical Pharmacology, 14(1). Retrieved from https://jptcp.com/index.php/jptcp/article/view/156
Issue
Section
Articles
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All articles published in JPTCP are licensed under Copyright Creative Commons Attribution-NonCommercial 4.0 International License.